03 Oct Valproate-containing Medicines – Potential Risk of Neurodevelopmental Disorders in Offspring of Fathers Treated With Valproate in the Three Months Prior to Conception
Posted at 10:31h
in
The document is a Dear Healthcare Professional (DHCP) letter informing healthcare professionals about the risk of neurodevelopment disorders in children born to fathers exposed valproate valproate-containing medicines three months before conception.
Download latest version
Document Number:
DHCPL
Version:
1
Date Updated:
03/10/2025
File Type:
pdf
Category:
Communication To Health Care Professionals